RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Defence Therapeutics Revenue 2024

Defence Therapeutics Revenue

0 CAD

Defence Therapeutics Dividend yield

Ticker

DTC.CN

ISIN

CA24463V1013

WKN

A3CN14

In 2024, Defence Therapeutics's sales reached 0 CAD, a 0% difference from the 0 CAD sales recorded in the previous year.

The Defence Therapeutics Revenue history

YEARREVENUE (undefined CAD)GROSS MARGIN (%)
2022--
2021--
2020--
2019--

Defence Therapeutics Aktienanalyse

What does Defence Therapeutics do?

Defence Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Defence Therapeutics's Sales Figures

The sales figures of Defence Therapeutics originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Defence Therapeutics’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Defence Therapeutics's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Defence Therapeutics’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Defence Therapeutics Stock

How much revenue did Defence Therapeutics generate this year?

Defence Therapeutics has achieved a revenue of 0 CAD this year.

How much was the turnover of the company Defence Therapeutics compared to the previous year?

The revenue of Defence Therapeutics has increased by 0% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Defence Therapeutics?

The revenue of Defence Therapeutics is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Defence Therapeutics measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Defence Therapeutics so important for investors?

The revenue of Defence Therapeutics is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Defence Therapeutics pay?

Over the past 12 months, Defence Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Defence Therapeutics is expected to pay a dividend of 0 CAD.

What is the dividend yield of Defence Therapeutics?

The current dividend yield of Defence Therapeutics is .

When does Defence Therapeutics pay dividends?

Defence Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Defence Therapeutics?

Defence Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Defence Therapeutics?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Defence Therapeutics located?

Defence Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Defence Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Defence Therapeutics from 5/18/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 5/18/2024.

When did Defence Therapeutics pay the last dividend?

The last dividend was paid out on 5/18/2024.

What was the dividend of Defence Therapeutics in the year 2023?

In the year 2023, Defence Therapeutics distributed 0 CAD as dividends.

In which currency does Defence Therapeutics pay out the dividend?

The dividends of Defence Therapeutics are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Defence Therapeutics

Our stock analysis for Defence Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Defence Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.